Skip to main content Accessibility help
×
Home
Hostname: page-component-684899dbb8-5dd2w Total loading time: 0.179 Render date: 2022-05-18T12:40:33.674Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }

Managing the Use and Dissemination of Information about Biomarkers: The Importance of Incentive Structures

Published online by Cambridge University Press:  01 January 2021

Abstract

The use of biomarkers holds great promise for the development of new therapeutics and the acceleration of clinical research. However, biomarkers must be validated — a complex and costly endeavor. Importantly, biomarker validation is meaningfully shaped by economic and policy-driven incentives.

Type
Symposium Articles
Copyright
Copyright © American Society of Law, Medicine and Ethics 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hey, S. P. et al., “Challenges and Opportunities for Biomarker Validation,” Journal of Law, Medicine & Ethics 47, no. 3 (2019): 357-361.CrossRefGoogle Scholar
Li, R. and Sim, I., “How Clinical Trial Data Sharing Platforms Can Advance the Study of Biomarkers,” Journal of Law, Medicine & Ethics 47, no. 3 (2019): 369-373; Shrager, J. et al., “Is Cancer Solvable? Towards Efficient and Ethical Biomedical Science,” Journal of Law, Medicine & Ethics 47, no. 3 (2019): 362-368.CrossRefGoogle Scholar
Mavergames, C. et al., “Cochrane's Linked Data Project: How It can Advance Our Understanding of Surrogate Endpoints,” Journal of Law, Medicine & Ethics 47, no. 3 (2019): 374-380; Hey, S. P. et al., “Surrogate Endpoints and Drug Regulation: What is Needed to Clarify the Evidence,” Journal of Law, Medicine & Ethics 47, no. 3 (2019): 381-387.CrossRefGoogle Scholar
Stern, A. D., Alexander, B. M., and Chandra, A., “Innovation Incentives and Biomarkers,” Clinical Pharmacology & Therapeutics 103, no. 1 (2018): 34-36.CrossRefGoogle Scholar
Stern, A. D., Alexander, B. M., and Chandra, A., “How Economics can Shape Precision Medicines,” Science 355, no. 6330 (2017): 1131-1133.CrossRefGoogle Scholar
Taichman, D. B., Sahni, P., Pinborg, A., Peiperl, L., Laine, C., James, A., Hong, S. T., Haileamlak, A., Gollogly, L., Godlee, F., and Frizelle, F. A., “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors,” JAMA 317, no. 24 (2017): 2491-2492; Califf, R. M., Zarin, D. A., Kramer, J. M., Sherman, R. E., Aberle, L. H., and Tasneem, A., “Characteristics of Clinical Trials Registered in ClinicalTrials.gov, 2007-2010,” JAMA 307, no. 17 (2012): 1838-1847.CrossRefGoogle Scholar

Save article to Kindle

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Managing the Use and Dissemination of Information about Biomarkers: The Importance of Incentive Structures
Available formats
×

Save article to Dropbox

To save this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about saving content to Dropbox.

Managing the Use and Dissemination of Information about Biomarkers: The Importance of Incentive Structures
Available formats
×

Save article to Google Drive

To save this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about saving content to Google Drive.

Managing the Use and Dissemination of Information about Biomarkers: The Importance of Incentive Structures
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *